The FDA issued the EU – the first vaccine for the general public to use in the United States – late Friday, a day after consultants recommended it. The FDA’s fast-paced victory over the White House was caught between public forces helping to fight an epidemic that killed 300,000 Americans, but there is deep skepticism about the new scientific technology being developed in a highly charged political environment. FDA Commissioner Dr. Stephen Hahn said when reviewing data on the Pfizer and Bioentech vaccine data, the agency’s scientists were on the rise. The FDA sought the advice of its Vaccine and Related Biological Products Advisory Committee (VRPPAC), a panel of experts who have no financial ties to the vaccination process, 17-4 Knowledge Vote to recommend the EUA for vaccination after two public meetings A vote. “We held a public consultation committee on Thursday on the use of Pfizer and Bioentech,” Han said. “The group largely agreed that the benefits of the vaccine outweigh the risks.” Han said the FDA was transparent about the data. Vaccination, “Hon. EUA is a process that is faster than full approval – it can take months or even years for a vaccine, but Dr. Peter Marks, head of the FDA’s immunization division, Center for Biological Assessment and Research, has repeatedly said that the EUA standard is more than required for a full license. Allergic reactions to two people who have been vaccinated in the UK, the FDA has added a warning language on the label of the vaccine, which warns of the possibility, and the fact that all vaccine sites have emergency supplies on hand to handle any allergic reaction. The control and prevention centers will ensure that, Han said.
Source